1. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40:136–54.
Article
2. Report and recommendations of the San Antonio conference on diabetic neuropathy. Consensus statement. Diabetes. 1988; 37:1000–4.
3. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve. 2005; 31:113–23.
Article
4. Perkins BA, Ngo M, Bril V. Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy. Muscle Nerve. 2002; 25:212–7.
Article
5. Tankisi H, Pugdahl K, Beniczky S, Andersen H, Fuglsang-Frederiksen A. Evidence-based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis. Clin Neurophysiol Pract. 2019; 4:214–22.
Article
6. Andersen H, Stålberg E, Falck B. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 1997; 20:1296–302.
Article
7. Baba M, Suzuki C, Ogawa Y. Severity grading system of diabetic neuropathy in type-2 diabetes by nerve conduction study: five-year prospective study on occurrence of diabetic foot, macroangiopathic events, and eventual death. JPN J Clin Neurophysiol. 2018; 46:71–7.
8. Tankisi H, Pugdahl K, Beniczky S, Andersen H, Fuglsang-Frederiksen A. The role of electrodiagnostic testing in patients referred with the suspicion of polyneuropathy. Muscle Nerve. 2020; 62:E66–7.
Article